Atara Biotherapeutics, Inc. (ATRA) key performance indicators and operating metrics (2 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Regulatory milestone payment eligible upon biologics license application approval | 31M | FY2025-Q4 |
| Objective response rate by independent oncologic and radiographic review | 48.80 percent | FY2025-Q2 |
Back to ATRA overview · ATRA earnings · ATRA holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.